A Review of Topical Corticosteroid Sprays for the Treatment of Inflammatory Dermatoses

Kyle A Habet MD [1], Sree S Kolli BA[1], Adrian Pona MD[1], Steven R Feldman MD, PhD [1,2,3] Affiliations: [1] Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina. [2] Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina, [3] Department of Social Sciences & Health Policy,…

Update on Hydroxychloroquine

Update on Hydroxychloroquine.

The latest study finds no benefit from hydroxychloroquine. Hydroxycholorquine was heralded as a potential game-changer for treating COVID-19. However, a new study shows that the drug is of little benefit.[1] This does not mean it should be written off as a potential treatment option. It has shown antiviral activity in-vitro and the rationale for its use is plausible. More evidence is still needed and clinical trials are still ongoing.